Globus Medical (GMED) Other financing activities (2011 - 2026)

Globus Medical (GMED) has reported Other financing activities for 16 consecutive years, with $11.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other financing activities rose 133.57% year-over-year to $11.0 million; the trailing twelve-month figure through Jun 2026 stood at $110.8 million (up 1.9% YoY), and the FY2025 full-year result was $89.8 million, down 18.73% from the prior year.
• Other financing activities fell to $11.0 million in Q2 2026 per GMED's latest filing, from $26.0 million in the prior quarter.
• Across five years, Other financing activities topped out at $69.3 million in Q4 2024 and bottomed at $1.0 million in Q4 2023.
• Historically, Other financing activities has averaged $16.2 million across 5 years, with a median of $11.0 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Other financing activities tumbled 93.29% in 2023, then jumped 6561.83% in 2024.
• Over 5 years, Other financing activities stood at $15.5 million in 2022, then sank by 93.29% to $1.0 million in 2023, then surged by 6561.83% to $69.3 million in 2024, then retreated by 9.42% to $62.8 million in 2025, then tumbled by 82.52% to $11.0 million in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $11.0 million, $26.0 million, and $62.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.